CClinicalTrials.gg
CompletedNCT00572247Updated Mar 7, 2012

The Psychiatric Rehabilitation Approach to Weight Loss

An interventional study of Psychiatric Rehabilitation Approach to Weight Loss in Schizophrenic Disorders, sponsored by University of Kansas. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2012-03-07.

Sponsored by University of Kansas · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Enrollment
133
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The primary aim of the project is to examine the efficacy of the Psychiatric Rehabilitation Weight Loss program in reduction of weight and body mass index (BMI.

Read the detailed description

The study involves 144 individuals who will be randomly assigned to the intervention group or treatment as usual group(control group). All Participants will undergo baseline assessment, assessment at week 12, week 24 and in year from baseline.

02

Conditions studied

  • Schizophrenic Disorders

Browse trials for

03

In context

Schizophrenia

3,471 studies on the registry are indexed under Schizophrenia; 472 are open to participants now.

This study's enrollment of 133 is above the median of 70 across 2,872 interventional studies indexed under Schizophrenia.

Browse Schizophrenia studies →

Lead sponsor

University of Kansas is the lead sponsor of 81 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • A diagnosis of serious mental illness,
  • Age 18 - 65
  • BMI > 25
  • Medication stable (there have been no changes in antipsychotic medications or mood stabilizers for the last 3 months).

Exclusion criteria

Exclusion Criteria:

  • Current or history of eating disorder
  • Pregnant or breast feeding
  • Uncontrolled HTN
  • Severe coronary artery disease
  • Severe valvular disease
  • Uncontrolled diabetes
  • Sustained arrhythmia
  • Insulin using severe physical limitations
  • Severe Lung Disorders
  • Diagnosis of MR or dementia
05

Study design

Phase
Not applicable
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
133 participants (actual)

Study arms

  • Experimental
    1

    Behavioral

    Behavioral: Psychiatric Rehabilitation Approach to Weight Loss

  • No intervention
    2

Interventions

  • BehavioralPsychiatric Rehabilitation Approach to Weight Loss

    The use of psychiatric rehabilitation as a way to lose weight

06

What researchers measure

Primary outcomes

  1. The reduction of weight and Body Mass Index (BMI)

    Time frame: Week 12, Week 24, 1 Year from Baseline Visit

Secondary outcomes

  1. Measure of waist circumference, health promotion practices, dietary intake assessment of physical activity

    Time frame: Baseline, 12 Weeks, 24 weeks, 1 year

07

Study locations

1 site
  • University of Kansas Medical Center
    Kansas City, Kansas 66160, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 7, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00572247
Lead sponsor
University of Kansas
Collaborators
National Institute of Mental Health (NIMH)
Responsible party
Sponsor
First posted
Dec 13, 2007
Start date
Jan 2007
Primary completion
Jan 2010
Completion
Dec 2010
Last update
Mar 7, 2012

Study contacts

Edna Hamera, PhD, RN, CS
principal investigator · University of Kansas Medical Center

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion